Index Fund Advisors’s Lisata Therapeutics LSTA Stock Holding History

Index Fund Advisors’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-696	Closed	-$9K	–	102
2021 Q4	$9K	Buy	+696	New	+$10.7K	﹤0.01%	98

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Index Fund Advisors's LSTA Position: Q1 2022 in Review

Index Fund Advisors sold out of Lisata Therapeutics (LSTA) in Q1 2022, closing a stake of 696 shares — an estimated $9K sold.

Index Fund Advisors first reported a position in LSTA in Q4 2021 and held it in 1 quarter. The position peaked at $9K in Q4 2021. 33 funds tracked by Wall St. Rank hold LSTA as of Q1 2022.

Index Fund Advisors reported no remaining Lisata Therapeutics position as of Q1 2022 after selling out during the quarter.
Index Fund Advisors sold 696 Lisata Therapeutics shares in Q1 2022, an estimated $9K.
Index Fund Advisors first reported a position in Lisata Therapeutics in Q4 2021 and held it in 1 quarter.
Index Fund Advisors's Lisata Therapeutics position peaked at $9K in Q4 2021.
33 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2022.

Based on Index Fund Advisors's 13F filing for Q1 2022, filed 25 Apr 2022.